Motoki Makuuchi
YOU?
Author Swipe
View article: Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study Open
Background This study evaluated the effectiveness of NUDT15 codon 139 genotyping in optimizing thiopurine treatment for inflammatory bowel disease (IBD) in Japan, using real-world data, and aimed to establish genotype-based treatment strat…
View article: Long‐term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease
Long‐term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease Open
Background Ustekinumab (UST), an antibody against the p40 subunit of interleukin‐12/23, has been proven to be effective in patients with Crohn's disease (CD). However, large, long‐term comparative studies of UST against anti‐‐tumor necrosi…
View article: EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE
EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE Open